Resources

Type of publications
Regions
Diseases
4906 results found
2024 ∙ ACIP
ACIP Evidence to Recommendations for Use of Moderna RSV Vaccine (mResvia) in All Adults Aged ≥75 years and in Adults Aged 60–74 at Increased Risk of Severe RSV Disease
Background paper Americas United States of America EtR framework RSV (Respiratory syncytial virus)
Download:
2024 ∙ NACI
Supplemental guidance from NACI on influenza vaccination in adults 65 years of age and older
Recommendation Americas Canada Older adults Influenza
Download:
2024 ∙ NACI
Addendum to the NACI statement on seasonal influenza vaccine for 2024-2025: Transition from quadrivalent to trivalent influenza vaccines
Recommendation Americas Canada Influenza
Download:
2024 ∙ NACI
NACI Statement on seasonal influenza vaccine for 2024–2025
Recommendation Americas Canada Influenza
Download:
2024 ∙ NACI
NACI Updated recommendations on human papillomavirus vaccines
Recommendation Americas Canada Human papillomavirus (HPV)
Download:
2024 ∙ SAGE
Extraordinary meeting of the Strategic Advisory Group of Experts on Immunization on Ebola vaccination, May 2024
Meeting report Ebola
Download:
2024 ∙ NIAC
recommendations for the passive immunisation of infants against Respiratory Synctytal Virus (RSV) during the 2024/2025 season
Recommendation Europe Ireland RSV (Respiratory syncytial virus)
Download:
2024 ∙ NIAC
Updated 2024 recommendations for COVID 19 vaccination
Recommendation Europe Ireland COVID-19
Download:
2024 ∙ Conseil Supérieur de la Santé (CSS)
Vaccination against seasonal influenza in Belgium - Winter season 2024-2025
Recommendation Europe Belgium Influenza
Download:
2024 ∙ STIKO
Modelling methods for predicting epidemiological and health economic effects of vaccinations. Guidance for analyses to be presented to the German Standing Committee on Vaccination (STIKO)
Functioning Europe Germany modelling
Download:
Loading...